Vaccinex (VCNX) Stock Chart & Stock Price History $0.70 -0.03 (-4.18%) As of 07/3/2025 12:42 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaccinex Stock Price Performance The Vaccinex (VCNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 89.53%, with a year-to-date return of -28.62%. In the past month, the stock has decreased 1.48%, reflecting recent market activity. As of the latest close, Vaccinex traded at $0.70 with a market cap of $1.82 million and volume of 1,921 shares. Five years ago, the stock traded at a split-adjusted price of $728.70, representing a 99.90% decrease over that period. At the time, it had a market cap of $60.09 million and a volume of 234 shares. Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.18%1 Month Performance-1.48%3 Month Performance+33.59%Year-To-Date Performance-28.62%1 Year Performance-89.53%5 Year Performance-99.90% VCNX Stock Chart for Friday, July, 4, 2025 VCNX Chart by TradingView Vaccinex Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.73$0.70-4.18%$0.73$0.581,921 shs$1.82 million07/02/2025$0.75$0.73-2.67%$0.75$0.73691 shs$1.90 million07/01/2025$0.73$0.75+2.74%$0.75$0.75117 shs$1.95 million06/30/2025$0.73$0.73$0.75$0.60826 shs$1.90 million06/27/2025$0.80$0.73-8.75%$0.80$0.587,547 shs$1.90 million06/26/2025$0.80$0.80$0.80$0.80280 shs$2.08 million06/25/2025$0.66$0.80+21.21%$0.80$0.80280 shs$2.08 million06/24/2025$0.78$0.66-15.38%$0.66$0.66519 shs$1.72 million06/23/2025$0.71$0.78+9.86%$0.80$0.5711,823 shs$2.03 million06/20/2025$0.71$0.71$0.71$0.7154 shs$1.85 million Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.71$0.71$0.71$0.7154 shs$1.85 million06/18/2025$0.71$0.71$0.71$0.7138 shs$1.85 million06/17/2025$0.71$0.71$0.72$0.713,555 shs$1.85 million06/16/2025$0.82$0.71-13.41%$0.72$0.713,555 shs$1.85 million06/13/2025$0.80$0.82+2.89%$0.82$0.821,046 shs$2.13 million06/12/2025$0.80$0.80$0.80$0.73687 shs$2.07 million06/11/2025$0.88$0.80-9.23%$0.80$0.73687 shs$2.07 million06/10/2025$0.90$0.88-2.44%$0.88$0.88506 shs$2.28 million06/09/2025$0.86$0.90+5.26%$0.93$0.72555 shs$2.34 million06/06/2025$0.71$0.86+20.42%$0.86$0.72504 shs$2.22 million06/05/2025$0.71$0.71$0.71$0.71112 shs$1.85 million06/04/2025$0.71$0.71$0.71$0.71459 shs$1.85 million06/03/2025$0.72$0.71-1.42%$0.71$0.71459 shs$1.85 million06/02/2025$0.92$0.72-22.12%$1.22$0.72927 shs$1.87 million Related Companies CLDI Stock Chart APLM Stock Chart ORGS Stock Chart PMCB Stock Chart SLXN Stock Chart CVM Stock Chart OMGA Stock Chart CELZ Stock Chart AIM Stock Chart INDP Stock Chart Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCNX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
